#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Thrombotic microangiopathy Myeloproliferative neoplasm Short stature Chronic myelomonocytic leukaemia Encephalopathy neonatal Cutaneous T-cell lymphoma Autoimmune hepatitis Inclusion body myositis Infantile spasms Adrenogenital syndrome Follicular lymphoma stage I T-cell type acute leukaemia Osteosarcoma recurrent Crohn's disease More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Life with Disease Myelodysplastic syndrome – Treatment Niemann-Pick disease – Diagnostics Nodal marginal zone B-cell lymphoma – Trials in Disease Systemic mastocytosis – Basic Information Rhabdomyosarcoma – Basic Information Mantle cell lymphoma Crigler-Najjar syndrome – Diagnostics Hereditary optic atrophy – Trials in Disease Undifferentiated sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betula Pendula Pollen Extract Phenprocoumon Avapritinib Hydrocortisone Acetate Fingolimod Hydrochloride Bomedemstat Darolutamide Betula Verrucosa (108) Degarelix Acetate Fostemsavir Remdesivir Bemarituzumab Lysine Aspirin Azelastine Hydrochloride Lactulose Ketotifen Hydrogen Fumarate Rigosertib Sodium Nimodipine Naproxen Dexamethasone Acetate More therapies…

    Learn about Your Condition

    Mechanical ventilation Crohn's disease Radius fracture Reperfusion injury Choroidal dystrophy Metastases to biliary tract Cardiac amyloidosis Skin bacterial infection Neuropathic arthropathy Intermittent claudication Foot deformity Anogenital warts Lung disorder Pyelonephritis Neonatal hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Squamous cell carcinoma of the hypopharynx

  • Evaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Cetuximab
    • Cisplatin
    • Tretinoin
    Belgium France Italy

  • Study on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal cancer recurrent
    • Squamous cell carcinoma of the oral cavity
    • Laryngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    Germany

  • Study on Fluorescence-Guided Surgery Using cRGD-ZW800-1 for Patients with Laryngeal and Hypopharyngeal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Crgd-Zw800-1
    The Netherlands

  • Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Afatinib
    Germany Spain

  • Study on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Laryngeal cancer
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Cisplatin
    • Dexamethasone
    • Docetaxel
    Germany

  • Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    • Laryngeal squamous cell carcinoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Germany
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!